Omeprazole oral suspension tariff redeterminations

Effective from September in England and Wales

The Department of Health and Social Care and the National Assembly of Wales have retrospectively determined from September 2023:

the addition of Omeprazole 1mg/ml oral suspension sugar free (75ml) to Category C based on Rosemont Pharmaceuticals Ltd
the deletion of Omeprazole 5mg/5ml oral suspension from Part VIIIB

Payment for September and October’s prescriptions will reflect the above retrospective determination and hence will not be as per the published Drug Tariff.

DM Zone news England Wales

Latest news

DDA raises rural GP issues in Westminster event

DDA Board Member Dr Ian Hume raised the rural challenges facing dispensing GPs in a Rebuild General Practice campaign roundtable with Liberal Democrat MPs.The discussion focused on the challenges facing GP practices across the country, from rising de

MSN: lansoprazole 15mg and 30mg orodispersible tablets

DHSC has published a Tier 2 Medicine Supply Notification (MSN) for lansoprazole 15mg and 30mg orodispersible tablets: limited supply until early January 2027. Up-to-date information abour medicine supply issues can be found in the DHSC and NHSE

England & Wales: August price redetermination

The Department of Health and Social Care has confirmed that the reimbursement price for the following products in the table have been redetermined. This is to reflect an increase in the NHS list price. Generic name Brand name Pack size Ne